Celldex Therapeutics (CLDX) Q2 2020 Earnings

6MayConfirmed
Q2 2019
Q3 2019
Q4 2019
Q2 2020
-1.4
-1.17
-0.94
-0.71

Details

Expected EPS
-0.71
Actual EPS
-0.73
Surprise EPS
-0.02
Surprise Percent
+2.82%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.73 per share for Q2 2020.

0 Comments

Share your thoughts